HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vivo and in vitro studies on renal uptake of radiolabeled affibody molecules for imaging of HER2 expression in tumors.

Abstract
Affibody molecules (6-7 kDa) are a new class of small robust three-helical scaffold proteins. Radiolabeled subnanomolar anti-HER2 affibody ZHER2:342 was developed for imaging of HER2 expression in tumors, and a clinical study has demonstrated that the (111)In- and (68)Ga-labeled affibody molecules can efficiently detect HER2 expressing metastases in breast cancer patients. However, a significant renal accumulation of radioactivity after systemic injection of a radiolabeled anti-HER2 affibody conjugate is observed. The aim of this study was to investigate the mechanism of renal reabsorption of anti-HER2 affibody at the molecular level. Renal accumulation of radiolabeled anti-HER2 affibody molecules was studied in a murine model and in vitro using opossum-derived proximal tubule (OK) cells. It was found that kidney reabsorption of affibody molecule was not driven by megalin/cubilin. Amino acids in the target-binding side of affibody molecule were involved in binding to OK cells. On OK cells, two types of receptors for anti-HER2 affibody molecule were found: KD1=0.8 nM, Bmax1=71,500 and KD2=9.2 nM, Bmax2=367,000. The results of the present study indicate that affibody molecule and other scaffold-based targeting proteins with a relatively low kidney uptake can be selected using in vitro studies with tubular kidney cells.
AuthorsMohamed Altai, Zohreh Varasteh, Karl Andersson, Annemarie Eek, Otto Boerman, Anna Orlova
JournalCancer biotherapy & radiopharmaceuticals (Cancer Biother Radiopharm) Vol. 28 Issue 3 Pg. 187-95 (Apr 2013) ISSN: 1557-8852 [Electronic] United States
PMID23461385 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Heterocyclic Compounds, 1-Ring
  • Immunoconjugates
  • Indium Radioisotopes
  • Radiopharmaceuticals
  • Recombinant Fusion Proteins
  • affibody (ZHER2-342)2
  • 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
  • Technetium
  • Receptor, ErbB-2
Topics
  • Animals
  • Cell Line, Tumor
  • Female
  • Heterocyclic Compounds, 1-Ring (chemistry, pharmacokinetics)
  • Humans
  • Immunoconjugates (pharmacokinetics)
  • Indium Radioisotopes (chemistry)
  • Kidney (metabolism)
  • Male
  • Mice
  • Molecular Imaging (methods)
  • Opossums
  • Ovarian Neoplasms (diagnostic imaging, metabolism)
  • Radiopharmaceuticals (pharmacokinetics)
  • Receptor, ErbB-2 (analysis, biosynthesis)
  • Recombinant Fusion Proteins (pharmacokinetics)
  • Technetium (chemistry)
  • Tissue Distribution
  • Tomography, Emission-Computed, Single-Photon

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: